Skip to main content

Featured

Nerve Block Therapy Offers Hope for Migraine Sufferers

                           Calgary neurologist Dr. Serena Orr injecting a patient to help treat migraines.  Researchers in Calgary are spotlighting a promising treatment for people living with severe migraines: occipital nerve blocks . This approach involves injecting a small amount of anesthetic near the occipital nerves at the back of the head, which can interrupt pain signals and provide rapid relief. Neurologist Dr. Serena Orr of the University of Calgary has been at the forefront of this research, recommending updates to the American Headache Society’s guidelines for emergency departments. The new recommendations encourage doctors to consider nerve blocks as a frontline option for patients arriving with debilitating migraine attacks. Patients who have received the treatment report significant improvement. Some describe it as the first time they’ve been able to escape the crushing pain, nausea,...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment